The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) study: a multicenter study

Raymond J Yost1, Diane M Cappelletty,

  • 1Department of Pharmacy, Lexington VA Medical Center, Kentucky, USA.

Pharmacotherapy
|September 20, 2011
PubMed
Abstract

Insights

Extended-infusion piperacillin-tazobactam significantly reduced mortality in gram-negative infections compared to standard dosing. This pharmacodynamic approach offers improved survival outcomes for critically ill patients.

Area of Science:

  • Pharmacology and Infectious Diseases
  • Antimicrobial Stewardship

Background:

  • Gram-negative bacterial infections pose a significant threat, necessitating effective antimicrobial strategies.
  • Optimizing antibiotic dosing, such as extended infusions, may improve therapeutic outcomes.
  • Piperacillin-tazobactam is a commonly used broad-spectrum antibiotic for serious infections.

Purpose of the Study:

  • To compare the effectiveness of extended-infusion piperacillin-tazobactam versus standard-infusion beta-lactam antibiotics.
  • To evaluate the impact on mortality and other clinical outcomes in patients with gram-negative infections.

Main Methods:

  • A multicenter, retrospective review of 359 adult patients with gram-negative infections.
  • Patients received either 4-hour extended-infusion piperacillin-tazobactam or nonextended-infusion comparator antibiotics.
  • Data collected included demographics, infection details, and clinical outcomes like mortality and length of stay.

Main Results:

  • In-hospital mortality was significantly lower in the extended-infusion piperacillin-tazobactam group (9.7% vs. 17.9%, p=0.02).
  • Extended-infusion piperacillin-tazobactam was associated with a reduced risk of mortality (OR 0.43, p=0.05).
  • Hospital and ICU length of stay were similar between the groups.

Conclusions:

  • Extended-infusion piperacillin-tazobactam demonstrates favorable outcomes, including reduced mortality, for gram-negative infections.
  • Pharmacodynamic dosing strategies may enhance the efficacy of beta-lactam antibiotics.
  • Further prospective, randomized trials are recommended to confirm these findings.

Related Concept Videos

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...